Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ashton, Michelle P ^a   Eugster, Anne ^a   Walther, Denise ^a   Daehling, Natalie ^a   Riethausen, Stephanie ^b   Kuehn, Denise ^a   Klingel, Karin ^c   Beyerlein, Andreas ^b   Zillmer, Stephanie ^b   Ziegler, Anette Gabriele ^b,d,e   Bonifacio, Ezio ^a,d,e  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d Forschergruppe Diabetes eV   (Germany)

^e GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CAPSID PROTEIN; GLUTAMATE DECARBOXYLASE; INSULIN;

ADOLESCENT; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CHILD; COXSACKIE VIRUS INFECTION; ENTEROVIRUS B; FEMALE; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ANTIBODIES; AUTOIMMUNITY; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; MALE;

EID: 84986893092     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32899     Document Type: Article

References (38)

1. Todd, J. A. Etiology of type 1 diabetes. Immunity 32, 457-467, doi: 10.1016/j.immuni.2010.04.001 (2010).
2. Ziegler, A. G. & Nepom, G. T. Prediction and pathogenesis in type 1 diabetes. Immunity 32, 468-478, doi: 10.1016/j. immuni.2010.03.018 (2010).
3. Beyerlein, A., Donnachie, E., Jergens, S. & Ziegler, A. G. Infections in Early Life and Development of Type 1 Diabetes. Jama 315, 1899-1901, doi: 10.1001/jama.2016.2181 (2016).
4. Beyerlein, A., Wehweck, F., Ziegler, A. G. & Pflueger, M. Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study. JAMA pediatrics 167, 800-807, doi: 10.1001/jamapediatrics.2013.158 (2013).
5. Honeyman, M. C. et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49, 1319-1324 (2000).
6. Laitinen, O. H. et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 63, 446-455, doi: 10.2337/db13-0619 (2014).
7. Stene, L. C. et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59, 3174-3180, doi: 10.2337/db10-0866 (2010).
8. Schmid, S. et al. Reduced IL-4 associated antibody responses to vaccine in early pre-diabetes. Diabetologia 45, 677-685, doi: 10.1007/s00125-002-0816-7 (2002).
9. Giannopoulou, E. Z. et al. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 58, 2317-2323, doi: 10.1007/s00125-015-3672-y (2015).
10. Krischer, J. P. et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58, 980-987, doi: 10.1007/s00125-015-3514-y (2015).
11. Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. Jama 309, 2473-2479, doi: 10.1001/jama.2013.6285 (2013).
12. Oikarinen, S. et al. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes 63, 655-662, doi: 10.2337/db13-0620 (2014).
13. Yeung, W. C., Rawlinson, W. D. & Craig, M. E. Enterovirus infection and type 1 diabetes mellitus: systematic review and metaanalysis of observational molecular studies. BMJ 342, d35, doi: 10.1136/bmj.d35 (2011).
14. Kaufman, D. L. et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. The Journal of clinical investigation 89, 283-292, doi: 10.1172/JCI115573 (1992).
15. Lonnrot, M. et al. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Childhood Diabetes in Finland Study Group. Clinical and experimental immunology 104, 398-405 (1996).
16. Muckelbauer, J. K. et al. The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3, 653-667 (1995).
17. Roivainen, M. et al. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Journal of medical virology 56, 74-78 (1998).
18. Dahlquist, G. G., Ivarsson, S., Lindberg, B. & Forsgren, M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 44, 408-413 (1995).
19. Hyoty, H. et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44, 652-657 (1995).
20. Viskari, H. et al. Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring. Diabetes care 35, 1328-1332, doi: 10.2337/dc11-2389 (2012).
21. Viskari, H. et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 48, 1280-1287, doi: 10.1007/s00125-005-1780-9 (2005).
22. McPhee, F., Zell, R., Reimann, B. Y., Hofschneider, P. H. & Kandolf, R. Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras. Virus research 34, 139-151 (1994).
23. Salur, L. et al. Enterovirus infections in young infants: are children still protected by maternal antibodies? Human vaccines 7, 966-971, doi: 10.4161/hv.7.9.16082 (2011).
24. Bian, X. et al. Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays. Diabetes 65, 285-296, doi: 10.2337/db15-0179 (2016).
25. Lipkin, W. I. & Anthony, S. J. Virus hunting. Virology 479-480, 194-199, doi: 10.1016/j.virol.2015.02.006 (2015).
26. Hou, J., Said, C., Franchi, D., Dockstader, P. & Chatterjee, N. K. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes 43, 1260-1266 (1994).
27. Eugster, A. et al. High diversity in the TCR repertoire of GAD65 autoantigen-specific human CD4+ T cells. J Immunol 194, 2531-2538, doi: 10.4049/jimmunol.1403031 (2015).
28. Eugster, A. et al. Measuring T cell receptor and T cell gene expression diversity in antigen-responsive human CD4+ T cells. Journal of immunological methods 400-401, 13-22, doi: 10.1016/j.jim.2013.11.003 (2013).
29. Hummel, S., Pfluger, M., Hummel, M., Bonifacio, E. & Ziegler, A. G. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes care 34, 1301-1305, doi: 10.2337/ dc10-2456 (2011).
30. Thumer, L. et al. German new onset diabetes in the young incident cohort study: DiMelli study design and first-year results. The review of diabetic studies: RDS 7, 202-208, doi: 10.1900/RDS.2010.7.202 (2010).
31. Ziegler, A. G., Meier-Stiegen, F., Winkler, C. & Bonifacio, E. Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty-TEENDIAB: study design. Pediatric diabetes 13, 419-424, doi: 10.1111/j.1399-5448.2011.00763.x (2012).
32. Ziegler, A. G., Hummel, M., Schenker, M. & Bonifacio, E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48, 460-468 (1999).
33. Lampasona, V. et al. Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clinical chemistry 57, 1693-1702, doi: 10.1373/clinchem.2011.170662 (2011).
34. Schlosser, M., Mueller, P. W., Torn, C., Bonifacio, E. & Bingley, P. J. Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia 53, 2611-2620, doi: 10.1007/s00125-010-1915-5 (2010).
35. Torn, C., Mueller, P. W., Schlosser, M., Bonifacio, E. & Bingley, P. J. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51, 846-852, doi: 10.1007/s00125-008-0967-2 (2008).
36. Catani, M. et al. Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients. Diabetologia 59, 294-298, doi: 10.1007/s00125-015-3792-4 (2016).
37. Berthold, M. R. et al. In Data Analysis, Machine Learning and Applications. (eds Christine Preisach, Hans Burkhardt, Lars Schmidt- Thieme & Reinhold Decker) 319-326 (Springer Berlin Heidelberg, 2008).
38. Lefranc, M. P. et al. IMGT, the international ImMunoGeneTics information system. Nucleic acids research 37, D1006-D1012, doi: 10.1093/nar/gkn838 (2009).